{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T16:05:56Z","timestamp":1779811556987,"version":"3.53.1"},"reference-count":76,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ccm.2025.12.019","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T21:31:27Z","timestamp":1774042287000},"page":"399-417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vaccines Against Pneumonia"],"prefix":"10.1016","volume":"47","author":[{"given":"Madelyn","family":"Renzetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Losier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccm.2025.12.019_bib1","unstructured":"Centers for Disease Control and Prevention, N.C.f.H.S. National Vital Statistics System, Mortality 2018-2023 on CDC WONDER Online Database. 2024 (cited 2025 January 10); Data are from the Multiple Cause of Death Files, 2018-2023, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program). Available at: http:\/\/wonder.cdc.gov\/ucd-icd10-expanded.html."},{"key":"10.1016\/j.ccm.2025.12.019_bib2","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/jama.2024.14796","article-title":"Community-acquired pneumonia: a review","volume":"332","author":"Vaughn VM","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.ccm.2025.12.019_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/B978-0-08-102723-3.00013-5","article-title":"Community-acquired pneumonia in childhood","author":"Popovsky EY","year":"2022","journal-title":"Encyclopedia of Respiratory Medicine"},{"key":"10.1016\/j.ccm.2025.12.019_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/00333549101250S305","article-title":"Influenza: the once and future pandemic","volume":"125","author":"Taubenberger JK","year":"2010","journal-title":"Public Health Rep"},{"key":"10.1016\/j.ccm.2025.12.019_bib5","author":"Organization"},{"key":"10.1016\/j.ccm.2025.12.019_bib6","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.10.020430","article-title":"Variability in published rates of influenza-associated hospitalizations: a systematic review, 2007-2018","volume":"10","author":"Roguski","year":"2020","journal-title":"J Glob Health"},{"key":"10.1016\/j.ccm.2025.12.019_bib7","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1001\/jama.2020.21869","article-title":"High-risk groups for influenza complications","volume":"324","author":"TM","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ccm.2025.12.019_bib8","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.vaccine.2017.01.018","article-title":"Improving the selection and development of influenza vaccine viruses - report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 ovember 2015","volume":"35","author":"Hampson","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.ccm.2025.12.019_bib10","author":"Organization"},{"issue":"5","key":"10.1016\/j.ccm.2025.12.019_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7305a1","article-title":"Prevention and control of seasonal Influenza with vaccines: recommendations of the advisory committee on immunization practices - United States, 2024-25 influenza season","volume":"73","author":"Grohskopf","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ccm.2025.12.019_bib12","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa1315727","article-title":"Efficacy of high-dose versus standard-dose influenza vaccine in older adults","volume":"371","author":"DiazGranados CA","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ccm.2025.12.019_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.anai.2022.01.026","article-title":"The adverse reactions to vaccines practice parameter 10 years on-what have we learned?","volume":"129","author":"JM","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.ccm.2025.12.019_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.anai.2017.10.020","article-title":"Administration of influenza vaccines to egg allergic recipients: a practice parameter update 2017","volume":"120","author":"Greenhawt","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.ccm.2025.12.019_bib18","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/cid\/ciae375","article-title":"Comparative effectiveness of licensed Influenza vaccines in preventing Influenza-related medical encounters and hospitalizations in the 2022-2023 Influenza season among adults >\/= 65 years of age","volume":"79","author":"Ku","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2025.12.019_bib19","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1111\/jgs.19176","article-title":"Protection against influenza hospitalizations from enhanced influenza vaccines among older adults: a systematic review and network meta-analysis","volume":"72","author":"Ferdinands JM","year":"2024","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ccm.2025.12.019_bib21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.15585\/mmwr.mm7103a4","article-title":"Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: updated Interim Recommendations from the Advisory Committee on Immunization Practices - United States, December 2021","volume":"71","author":"Oliver","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ccm.2025.12.019_bib22","article-title":"Technological breakthroughs and advancements in the application of mRNA vaccines: a comprehensive exploration and future prospects","volume":"16","author":"Wei","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.ccm.2025.12.019_bib23","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","article-title":"Innate immune mechanism of mRNA vaccines","volume":"55","author":"Verbeke","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.ccm.2025.12.019_bib24","doi-asserted-by":"crossref","first-page":"819","DOI":"10.15585\/mmwr.mm7337e2","article-title":"Use of COVID-19 Vaccines for Persons > 6 months: recommendations of the Advisory Committee on Immunization Practives - United States, 2024-2025","volume":"73","author":"Panagiotakopoulos","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ccm.2025.12.019_bib28","article-title":"FDA","year":"2024","journal-title":"SPIKEVAX"},{"key":"10.1016\/j.ccm.2025.12.019_bib29","article-title":"FDA","year":"2024","journal-title":"COMIRNATY"},{"key":"10.1016\/j.ccm.2025.12.019_bib32","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.15585\/mmwr.mm7349a2","article-title":"Use of additional doses of 2024\u20132025 COVID-19 vaccine for adults aged \u226565 years and persons aged \u22656 months with moderate or severe immunocompromise: recommendations of the Advisory Committee on immunization practices \u2014 united States, 2024","volume":"73","author":"Roper LE","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ccm.2025.12.019_bib33","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.7326\/M22-2274","article-title":"Incidence of Myocarditis\/Pericarditis following mRNA COVID-19 vaccination among children and younger adults in the United States","volume":"175","author":"Goddard","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccm.2025.12.019_bib34","article-title":"Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study","volume":"6","author":"Kracalik","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.ccm.2025.12.019_bib36","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3390\/vaccines9050467","article-title":"Efficacy and safety of COVID-19 vaccines: a systematic review and meta-analysis of randomized clinical trials","volume":"9","author":"Pormohammad A","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.ccm.2025.12.019_bib37","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/cid\/ciae132","article-title":"Effectiveness of the 2023-2024 formulation of the COVID-19 messenger RNA vaccine","volume":"79","author":"Shrestha","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2025.12.019_bib38","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2025.12.019_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3947\/ic.2024.0011","article-title":"Epidemiology and disease burden of respiratory syncytial virus infection in adults","volume":"56","author":"Kim","year":"2024","journal-title":"Infect Chemother"},{"key":"10.1016\/j.ccm.2025.12.019_bib40","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/thoraxjnl-2018-212212","article-title":"Respiratory Syncytial virus (RSV): a scourge from infancy to old age","volume":"74","author":"Coultas","year":"2019","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2025.12.019_bib45","doi-asserted-by":"crossref","first-page":"920","DOI":"10.15585\/mmwr.mm7234a4","article-title":"Use of nirsevimab for the prevention of the respiratory syncytial virus disease among infants and young children: recommendations of the Advisory Committee on immunization practices - united States, 2023","volume":"72","author":"Jones JM","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ccm.2025.12.019_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.107118","article-title":"Efficacy and safety of vaccines to prevent respiratory syncytial virus infection in infants and older adults: a systematic review and meta-analysis","volume":"146","author":"Zeng","year":"2024","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ccm.2025.12.019_bib47","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.15585\/mmwr.mm7241e1","volume":"72","author":"Fleming-Dutra KE","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"32","key":"10.1016\/j.ccm.2025.12.019_bib49","doi-asserted-by":"crossref","first-page":"696","DOI":"10.15585\/mmwr.mm7332e1","article-title":"Use of respiratory syncytial virus vaccines in adults aged \u226560 years: updated recommendations of the advisory committee on immunization practices -United States, 2024","volume":"73","author":"Britton","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ccm.2025.12.019_bib50","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","article-title":"Efficacy and safety of an mRNA-Based RSV PreF Vaccine in older adults","volume":"389","author":"Wilson","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccm.2025.12.019_bib51","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S0140-6736(24)01738-0","article-title":"Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023 to March, 2024: a test-negative design analysis","volume":"404","author":"Payne","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2025.12.019_bib52","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/cid\/ciae010","article-title":"Efficacy and safety of respiratory syncytial virus (RSV) prefusion F protein vaccine (RSVPreF3 OA) in older adults pver 2 RSV seasons","volume":"78","author":"Ison","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2025.12.019_bib54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.15585\/mmwr.mm6701a7","article-title":"Recommendation of the Advisory Committee on Immunization Practices for use of a third dose of mumps virus-containing vaccine in persons at increased risk for mumps during an outbreak","volume":"67","author":"Marin M","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ccm.2025.12.019_bib55","series-title":"StatPearls [Internet]","article-title":"MMR vaccine","author":"Patel","year":"2025"},{"key":"10.1016\/j.ccm.2025.12.019_bib56","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(99)01239-8","article-title":"Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association","volume":"353","author":"Taylor","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2025.12.019_bib57","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/bmj.322.7284.460","article-title":"Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis","volume":"322","author":"Kaye","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.ccm.2025.12.019_bib58","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jama.285.9.1183","article-title":"Time trends in autism and MMR immunization coverage in California","volume":"285","author":"Dales","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ccm.2025.12.019_bib59","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1542\/peds.2005-2993","article-title":"Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations","volume":"118","author":"Fombonne","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.ccm.2025.12.019_bib60","first-page":"369","volume":"40","year":"1991","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ccm.2025.12.019_bib61","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/jamapediatrics.2013.4342","article-title":"Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience","volume":"168","author":"Papania MJ","year":"2014","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.ccm.2025.12.019_bib62","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.15585\/mmwr.mm6642a6","article-title":"Progress toward regional measles elimination\u2014worldwide, 2000\u20132016","volume":"66","author":"Dabbagh A","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ccm.2025.12.019_bib63","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2025-071332","article-title":"What\u2019s old is new again: measles","volume":"155","author":"Naureckas Li","year":"2025","journal-title":"Pediatrics"},{"key":"10.1016\/j.ccm.2025.12.019_bib64","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/resp.12978","article-title":"Seasonality of pathogens causing community-acquired pneumonia","volume":"22","author":"Cilloniz","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.ccm.2025.12.019_bib66","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1016\/j.vaccine.2017.05.075","article-title":"Pneumococcal conjugate vaccine use in adults- addressing an unmet medical need for non-bacteremic pneumococcal pneumonia","volume":"35","author":"Sings","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.ccm.2025.12.019_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.mm7401a1","article-title":"Expanded recommendations for use of pneumococcal conjugate vaccines among adults aged > 50 years: recommendations of the Advisory Committee on Immunization Practices -United States, 2024","volume":"74","author":"Kobayashi","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ccm.2025.12.019_bib69","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pnuemonia in adults","volume":"372","author":"Bonten MJM","year":"2015","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ccm.2025.12.019_bib70","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.cmi.2024.09.006","article-title":"Comparative effectiveness of pneumococcal vaccination strategies to prevent invasive pneumococcal disease: a population-based cohort study at the veterans health administration in the United States","volume":"31","author":"Hasegawa","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ccm.2025.12.019_bib71","doi-asserted-by":"crossref","first-page":"109","DOI":"10.15585\/mmwr.mm7104a1","article-title":"Use of 15-valent Pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. adultes: updated recommendations of the Advisory Committee on Immunization Practices - United States, 2022","volume":"71","author":"Kobayashi","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ccm.2025.12.019_bib72","doi-asserted-by":"crossref","first-page":"793","DOI":"10.15585\/mmwr.mm7336a3","article-title":"Use of 21-valent pneumococcal conjugate vaccine among U.S. adults: recommendations of the Advisory Committee on Immunization Practices - united States, 2024","volume":"73","author":"Kobayashi","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"10.1016\/j.ccm.2025.12.019_bib73","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1080\/14760584.2020.1825948","article-title":"Haemophilus influenzae type b disease in the era of conjugate vaccines: critical factors for successful eradication","volume":"19","author":"Slack","year":"2020","journal-title":"Exp Rev of Vaccines"},{"key":"10.1016\/j.ccm.2025.12.019_bib74","doi-asserted-by":"crossref","first-page":"6168","DOI":"10.1016\/j.vaccine.2013.10.045","article-title":"Haemophilus influenzae type b (Hib) vaccination WHO position paper: july 2013 - recommendations","volume":"31","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ccm.2025.12.019_bib76","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-021-02049-7","article-title":"National and provincial impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in China: a modeling analysis","volume":"19","author":"Zhang","year":"2021","journal-title":"BMC Med"},{"key":"10.1016\/j.ccm.2025.12.019_bib77","doi-asserted-by":"crossref","first-page":"S321","DOI":"10.1093\/infdis\/jiaa537","article-title":"Hib vaccines: their impact on Haemophilus influenzae type b disease","volume":"224","author":"JR","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ccm.2025.12.019_bib78","first-page":"433","article-title":"Weekly epidemologic record - pertussis vaccines: WHO position paper - august 2015","volume":"35","author":"Organization","year":"2015","journal-title":"Weekly Epid Record"},{"key":"10.1016\/j.ccm.2025.12.019_bib79","doi-asserted-by":"crossref","first-page":"77","DOI":"10.15585\/mmwr.mm6903a5","article-title":"Use of tetanus toxoid, reduced diptheria toxoid, acellular pertussis vaccines: updated recommendations of the Advisory Committee on Immunization Practives - United States, 2019","volume":"69","author":"Havers","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ccm.2025.12.019_bib80","article-title":"Safety of pertussis vaccination in pregnant women in UK: observational study","volume":"349","author":"Donegan","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.ccm.2025.12.019_bib81","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1001\/jama.2014.3633","article-title":"Safety and immunogenicity of tetanus diptheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial","volume":"311","author":"Munoz","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ccm.2025.12.019_bib82","article-title":"Pertussis vaccine in COPD and asthma: an old acquaintance is back","volume":"4","author":"Villar-Alvarez","year":"2021","journal-title":"Open Respir Arch"},{"key":"10.1016\/j.ccm.2025.12.019_bib83","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)06508-2","article-title":"Randomised controlled trial of 2-component, 3-component, and 5-component acellular pertussis vaccines compared with whole-cell pertussis vaccine: ad hoc group for the study of pertussis vaccines","volume":"350","author":"Olin","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2025.12.019_bib84","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM199602083340602","article-title":"A controlled trial of a 2-component acellular, a 5-component acellular and a whole-cell pertussis vaccine","volume":"334","author":"Gustafsson","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccm.2025.12.019_bib85","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0140-6736(21)00984-3","article-title":"Measuring routine childhood vaccination coverage in 204 countries and territories, 1980-2019: a systematic analysis for the global burden of dissease study 2020, Release 1","volume":"398","author":"Collaborators","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2025.12.019_bib86","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-44943-7","article-title":"Maternal pertussis immunization and the blunting of routine vaccine effectiveness: a meta-analysis and modeling study","volume":"15","author":"Briga","year":"2024","journal-title":"Nat Commun"},{"issue":"10441","key":"10.1016\/j.ccm.2025.12.019_bib87","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/S0140-6736(24)00850-X","article-title":"Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization","volume":"403","author":"Shattock","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2025.12.019_bib88","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s40545-023-00654-w","article-title":"Thinking outside of the [cold] box: implementing a human-centered design approach to understand barriers and craft solutions to cold chain equipment maintenance in Niger","volume":"16","author":"Prosser","year":"2023","journal-title":"J Pharm Policy Pract"},{"key":"10.1016\/j.ccm.2025.12.019_bib89","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.15585\/mmwr.mm7346a1","article-title":"Influenza, COVID-19, and respiratory syncytial virus vaccination coverage among adults - united States, fall 2024","volume":"73","author":"Kriss","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ccm.2025.12.019_bib90","article-title":"Vaccine uptake and barriers to vaccination among at-risk adult populations in the US","volume":"18","author":"Kolobova","year":"2022","journal-title":"Humm Vaccin Immunother"},{"key":"10.1016\/j.ccm.2025.12.019_bib91","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.pcl.2022.11.001","article-title":"State of vaccine hesistancy in the United States","volume":"70","author":"Nowak","year":"2023","journal-title":"Pediatr Clin N Am"},{"key":"10.1016\/j.ccm.2025.12.019_bib92","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12992-023-00998-7","article-title":"Geographical and practical challenges in the implementation of digital health passports for cross-border COVID-19 pandemic management: a narrative review and framework for solutions","volume":"19","author":"Towett G","year":"2023","journal-title":"Global Health"},{"key":"10.1016\/j.ccm.2025.12.019_bib93","article-title":"Expanding vaccination access in underserved communities across Maryland through a collaborative approach","volume":"21","author":"Brandt","year":"2025","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.ccm.2025.12.019_bib94","article-title":"The role of trust in engaging community-based task forces and agencies among minoritized communities during a public health emergency","author":"Blake-Hepburn","year":"2025","journal-title":"Can J Pub Health"},{"key":"10.1016\/j.ccm.2025.12.019_bib95","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3390\/vaccines12080891","article-title":"Lessons from the COVID-19 pandemic: promoting vaccination and public health resilience, a narrative review","volume":"12","author":"Pennisi","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.ccm.2025.12.019_bib96","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ccm.2022.11.018","article-title":"The impact of coronavirus disease 2019 on viral, bacterial, and fungal respiratory infections","volume":"55","author":"Losier A","year":"2023","journal-title":"Clin Chest Med"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523125001212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523125001212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T15:38:46Z","timestamp":1779809926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523125001212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0272523125001212"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2025.12.019","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccines Against Pneumonia","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2025.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}